AKAP7

AKAP7
National Center for Biotechnology Information, U.S. National Library of Medicine · Public domain · source
Name	A-kinase anchor protein 7
Other names	AKAP15, AKAP18
Uniprot	Q9Y6M4
Gene	AKAP7
Organism	Homo sapiens

AKAP7 is a member of the A-kinase anchoring protein family that organizes protein kinase A near specific substrates to regulate cellular signaling. Identified through biochemical fractionation and molecular cloning efforts, AKAP7 coordinates phosphorylation events by scaffolding enzymes and ion channels important in cardiac, neuronal, and renal physiology. Studies by research groups at institutions such as Harvard University, Stanford University, Massachusetts Institute of Technology, University of Cambridge, and Max Planck Society contributed to its characterization.

Structure and Isoforms

AKAP7 encodes multiple splice variants produced by alternative splicing and promoter usage, giving rise to isoforms often referred to in literature with lengths around 15–44 kDa identified by mass spectrometry in labs at Cold Spring Harbor Laboratory and The Scripps Research Institute. Structural elements include amphipathic helices forming the canonical PKA regulatory subunit docking site characterized by solution NMR and X-ray crystallography groups at European Molecular Biology Laboratory and University of Oxford. Isoforms contain differing N-terminal sequences that mediate subcellular targeting comparable to isoform-specific targeting seen in AKAP9 and AKAP79. Predicted secondary structure and coiled-coil domains were modeled using algorithms from National Center for Biotechnology Information and validated with mutational analyses performed in collaboration with investigators at Johns Hopkins University.

Function and Mechanism

AKAP7 scaffolds regulatory subunits of protein kinase A and coordinates phosphorylation of substrates in complexes akin to scaffolding modules discovered in studies led by teams at Yale University and UCSF Medical Center. Mechanistically, AKAP7 binds PKA via an amphipathic helix and positions protein phosphatase complexes, phosphodiesterases like PDE4, and calcium-handling proteins to modulate cAMP-dependent signaling cycles described in research at University of California, Berkeley and Imperial College London. AKAP7-dependent targeting alters substrate phosphorylation kinetics in pathways implicated in excitation–contraction coupling and synaptic plasticity, paralleling mechanisms reported for mAKAP and Gravin in functional proteomics projects at European Bioinformatics Institute.

Tissue Expression and Localization

Expression profiling using RNA-seq datasets from The Human Protein Atlas, ENCODE Project Consortium, and microarray studies from Broad Institute show AKAP7 transcripts enriched in heart, brain, and kidney. Immunolabeling experiments carried out by groups at Columbia University and University of Pennsylvania localize AKAP7 isoforms to sarcolemma, t-tubules, postsynaptic densities, and apical membranes, overlapping localization patterns with proteins such as L-type calcium channel subunits and ryanodine receptor 2. Subcellular fractionation studies at Washington University in St. Louis detected membrane-associated and cytosolic pools, with isoform-specific targeting reminiscent of localization differences reported for AKAP5.

Regulation and Post-translational Modifications

AKAP7 function is regulated by phosphorylation, myristoylation, and protein–protein interactions mapped by phosphoproteomics consortia including teams from European Proteomics Association and ProteomeXchange. Site-specific phosphorylation by kinases such as PKA, PKC, and CaMKII modulates binding affinities for regulatory subunits and effectors; these modifications were characterized using mass spectrometers procured from vendors like Thermo Fisher Scientific and analyzed in core facilities at University of Toronto. Ubiquitination and proteasomal turnover pathways involving E3 ligases studied at University of California, San Diego contribute to isoform-specific stability, paralleling degradation mechanisms identified for other scaffold proteins including PSD-95.

Clinical Significance and Disease Associations

Genetic and proteomic studies link AKAP7 perturbations to cardiac arrhythmias, heart failure, and altered renal salt handling reported in clinical research centers such as Mayo Clinic, Cleveland Clinic, and Mount Sinai Hospital. Mouse models generated at The Jackson Laboratory and translational studies at Karolinska Institutet indicate that AKAP7 disruption affects calcium cycling and contractility, implicating it in pathophysiology resembling defects associated with mutations in RYR2 and SCN5A. Neurological associations include potential roles in synaptic dysfunction studied in cohorts at University College London and McGill University, suggesting relevance to disorders investigated by consortia like Alzheimer's Disease Neuroimaging Initiative.

Interactions and Signaling Pathways

AKAP7 engages in macromolecular complexes with PKA regulatory subunits, phospholamban, ryanodine receptors, L-type calcium channels, and phosphatases such as PP1 and PP2A, as shown by co‑immunoprecipitation and proximity labeling performed at Salk Institute and Fred Hutchinson Cancer Research Center. These interactions place AKAP7 within signaling networks including cAMP/PKA cascades, calcium-induced calcium release, and beta-adrenergic receptor pathways characterized in pharmacology studies at GlaxoSmithKline and Pfizer. Pathway enrichment analyses using gene sets from KEGG and Reactome link AKAP7-containing complexes to cardiac excitation–contraction coupling, synaptic transmission, and renal transport processes, with perturbation studies leveraging CRISPR/Cas9 platforms developed at Broad Institute and Addgene.

Category:Human proteins